Geert Kersten - Nov 19, 2021 Form 4 Insider Report for CEL SCI CORP (CVM)

Role: Chief Executive Officer, Director
Signature: Geert Kersten
Stock symbol: CVM
Transactions as of: Nov 19, 2021
Transactions value $: $500
Form type: 4
Date filed: 11/29/2021, 08:17 AM
Previous filing: Oct 4, 2021
Next filing: Jan 3, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVM	Options	Award	$500	+50K	+1.34%	$0.01^*	3.78M	Nov 19, 2021	Common Stock	50K	$10.48	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.48 per share. The stock options vest 100% upon the approval of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia. None of the options will be exercisable before November 19, 2022.

Content

Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.48 per share. The stock options vest 100% upon the approval of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia. None of the options will be exercisable before November 19, 2022.